Northwire Canada EditionMonday, July 13, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
M&A / Property

MTL Cannabis Announces Mailing of the Management Information Circular in Connection with its Special Meeting of Shareholders to Approve the Acquisition by Canopy Growth

MTLC · Price

Executive Summary

  • MTL Cannabis mailed its Management Information Circular and proxy materials for a special shareholders’ meeting scheduled for Feb 17, 2026 to approve the proposed arrangement whereby Canopy Growth will acquire all outstanding MTL shares.
  • The board unanimously recommends voting FOR the Arrangement, citing an estimated 82% premium to the Dec‑12‑2025 closing price and expected liquidity, scale, and cost synergies (≈ $10 M annually).
  • An interim court order authorizes the meeting; a final Supreme Court of British Columbia order is anticipated by Feb 23, 2026 with closing of the transaction expected by end‑Feb 2026.

Key Details

  • Consideration per MTL Share: 0.32 Canopy Growth common share plus $0.144 cash.
  • Premiums: ~82% above CSE closing price on Dec 12 2025; ~57% above 30‑day VWAP (based on Canopy shares).
  • Liquidity Benefits: Cash portion provides immediate funds; Canopy shares listed on Nasdaq Global Select and TSX with average daily volume > $35 M, offering substantially greater trading liquidity.
  • Strategic Rationale:
  • Access to Canopy’s global cannabis platform (Europe, Australia, indirect U.S. exposure).
  • Enhanced capital‑market presence and access to growth financing for shareholders.
  • Retention of key MTL management to bolster cultivation/operations expertise.
  • Expansion of Canopy’s medical‑cannabis footprint in Canada; cost synergies estimated at ~$10 M annually over 18 months.
  • Board & Shareholder Support: Board and special committee unanimously recommend the arrangement; directors/officers representing ~75% of shares have entered support/lock‑up agreements to vote FOR.
  • Voting Requirements: Must achieve (i) ≥ 66⅔ % of votes cast by shareholders present or represented by proxy, and (ii) a majority of votes cast in person or by proxy, excluding excluded shares per MI 61‑101.
  • Court Orders & Timeline:
  • Interim order from BC Supreme Court dated Jan 14 2026 authorizes the meeting.
  • Final court order hearing set for Feb 23 2026.
  • Expected closing of arrangement by end of February 2026, subject to all approvals and conditions.
  • Shareholder Assistance: Laurel Hill Advisory Group provides voting help via toll‑free (1‑877‑452‑7184), international line (1‑416‑304‑0211), text “Info”, or email [email protected].

Notable Quotes

(Optional – no direct quotes provided in the release.)

Read the original news release →

More from MTL Cannabis Corp.